LY1
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2561   -1.3776    0.3589 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1747   -0.8541   -0.6640 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7408    0.4602   -0.3493 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7249    1.6007   -0.3071 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7681    1.4515    0.8688 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3729    0.5485    0.4727 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6328    1.1285    0.2639 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6984    0.3491   -0.1683 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5188   -1.0157   -0.3795 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2567   -1.6148   -0.1863 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1547   -0.8272    0.2213 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9120   -1.9080   -0.8958 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0765   -3.3225   -0.4505 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 11  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 11  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 12  1  0
 10 11  2  0
 10 13  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB04273

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02072

>  <COMMON_NAME>  (1) 
8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine

>  <UNII>  (1) 
2K2UE2I8AY

$$$$
